September 18, 2014 8:47 PM ET

Biotechnology

Company Overview of Idenix Pharmaceuticals Inc.

Executive Profile

John McHutchinson M.D.

Former Member of Hepatitis Advisory Board, SciClone Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. John McHutchison, M.D. serves as an Associate Professor of Medicine at Duke University, Durham, North Carolina. Dr. McHutchison serves as a Member of Hepatitis Scientific Advisory Board of Idenix Pharmaceuticals Inc. He served as a Member of Hepatitis Advisory Board of Sciclone Pharmaceuticals, Inc.

Corporate Headquarters

320 Bent Street
Cambridge, Massachusetts 02141

United States

Phone: 617-995-9800
Fax: 617-995-9801

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Christopher Nishan Garabedian Chief Executive Officer, President and Director
Sarepta Therapeutics, Inc.
$580.0K
Arthur P. Bedrosian J.D.Chief Executive Officer, President, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$539.0K
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
$621.0K
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
--
Jeffrey M. Yordon Founder, Chairman and Chief Executive Officer
Sagent Pharmaceuticals, Inc.
$615.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Idenix Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.